UNION Therapeutics A/S (Association), a clinical stage and drug improvement organization focused on immunology, reports effective culmination of the ADESOS stage 2b, randomized, dose finding study assessing orismilast as an oral treatment in 233...
During the BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the Emirate's healthcare regulator, entered into a Memorandum of Understanding (MoU) with Pfizer Gulf FZ LLC, a global pharmaceutical firm...
Nu-Tek BioSciences is an innovative developer of crucial raw materials used in cell culture media for pharmaceutical development and production. Nu-Tek has signed an agreement with IMCD to distribute its peptones and hydrolysates throughout Europe...
QurAlis Enterprise (QurAlis) reported that it has gone into a exclusive license agreement with Eli Lilly and Company (Lilly) in which QurAlis is conceding Lilly worldwide privileges to create and popularize QRL-204, a possibly top tier splice...
Aurigene Pharmaceutical Services Limited (“Aurigeneâ€), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft.in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed...
BD (Becton, Dickinson and Company), a main worldwide medical technology firm, and Edwards Lifesciences reported a conclusive arrangement under which BD will buy Edwards' critical Care product group (Critical Care), a worldwide forerunner in...
Massive Bio, an international leader in AI-driven oncology solutions, and Un Ensayo Para Mi (UEPM), Latin America's foremost clinical trial search portal, are pleased to announce an expanded collaboration. This agreement will expand Massive Bio's...
Moderna, Inc, a bitotechnology firm, reported that the US Food and Medication Organization (FDA) has sanctioned mRESVIA (mRNA-1345), a mRNA respiratory syncytial vaccine (RSV) immunization, to protect adults of 60 years and more established from...
Nxera Pharma Co. Ltd and PrecisionLife, the Causal AI medication organization, report the development of their key Research and development partnership into auto-immune disorders with the possibility to distinguish new medication focuses for the...
The growth-oriented biopharmaceutical company Xeris Biopharma Holdings, Inc., dedicated to enhancing patient lives through the development and commercialization of cutting-edge products across a spectrum of therapies, has released the topline...
, CDSCO.jpg)
.jpg)